HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jouni Tuisku Selected Research

KF18446

1/2021Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jouni Tuisku Research Topics

Disease

6Inflammation (Inflammations)
01/2022 - 09/2013
4Multiple Sclerosis
02/2022 - 06/2014
3Neuroinflammatory Diseases
01/2022 - 01/2020
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2020
1Parkinson Disease (Parkinson's Disease)
01/2021
1Dementia (Dementias)
01/2021
1Cognitive Dysfunction
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Mental Disorders (Mental Disorder)
01/2020
1Opiate Overdose
01/2019
1Alcoholism (Alcohol Abuse)
01/2019
1Gambling (Pathological Gambling)
01/2019
1Psoriatic Arthritis
09/2016
1Pathologic Processes
09/2016
1Psoriasis (Pustulosis Palmaris et Plantaris)
09/2016
1Encephalitis (Encephalitis, Rasmussen)
06/2014
1Chronic Progressive Multiple Sclerosis
09/2013

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
02/2022 - 06/2014
3Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2014
2Apolipoproteins E (ApoE)IBA
01/2022 - 01/2021
1Amyloid beta-PeptidesIBA
01/2022
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Adenosine (Adenocard)FDA LinkGeneric
01/2021
1KF18446IBA
01/2021
1C-Reactive ProteinIBA
01/2021
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2021
1Polytetrafluoroethylene (Teflon)FDA Link
01/2020
1Chemokine CCL22IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1carfentanil (carfentanyl)IBA
01/2020
1ChemokinesIBA
01/2020
1Natalizumab (Tysabri)FDA Link
01/2019
1Naloxone (Narcan)FDA LinkGeneric
01/2019
1Opioid Receptors (Opioid Receptor)IBA
01/2019
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2019
1Nasal SpraysIBA
01/2019
1Fingolimod Hydrochloride (FTY720)FDA Link
10/2017
1MannansIBA
09/2016
1Biological ProductsIBA
09/2016
1Fluorine-18IBA
09/2016
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2015
1LigandsIBA
06/2014
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
09/2013